Pediatric Clinical Trials
As one of the top academic medical centers in the country and the only National Cancer Institute-designated cancer center in North Texas, we lead and participate in a number of clinical trials aimed at improving the outcomes of patients with cancer. Our department enrolls approximately 200 new patients in clinical trials each year.
Through our relationship with the Children’s Oncology Group (COG), a National Cancer Institute-supported clinical trials group, our pediatric oncologists have access to the latest treatments, information, and support from all over the world. In addition, we recently joined the Pediatric Early Phase Clinical Trial Network (PEP-CTN) as one of only a few institutions within the COG approved for early phase experimental new drug trials.
Clinical trials are critical in developing new therapies for cancer and can mean having access to new medication, groundbreaking research, and additional clinical care. Our clinical trials team is comprised of radiation oncologists, radiation biologists, clinical research coordinators, quality assurance coordinators, and clinical data specialists.
Non-Therapeutic
PROMISE - Video-Based Motion Detection and Prediction for Pediatric Radiotherapy.